| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80705 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80710 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82048-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-18646-0.02mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-18644-0.02mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26874-25ul | |||
| Azide and BSA Free | NBP3-44140 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43978 | |||
| BSA Free | NBP2-30982-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49015-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-88120-25ul | |||
![Western Blot: EBI3 Antibody (10J763) [NBP2-03939] - Western blot analysis of mouse thymus tissue using EBI3 antibody at a concentration of 1 ug/ml.](http://images.novusbio.com/fullsize/EBI3-Antibody-10J763-Western-Blot-NBP2-03939-img0004.jpg "Western Blot: EBI3 Antibody (10J763) [NBP2-03939] - Western blot analysis of mouse thymus tissue using EBI3 antibody at a concentration of 1 ug/ml.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: IL-27/IL-35 EBI3 Subunit Antibody (10J763) [NBP2-03939] - EBI3 Antibody (10J763) [NBP2-03939] - Figure A: Intracellular analysis of mouse IL-35 in transfected and untransfected HEK 293 cells (Brefeldin A treated, 5 hours) using mouse EBI3 antibody at 3 ug/10^6 cells. Figure B: Intracellular analysis of mouse EBI3 in stimulated and unstimulated RAW cells (LPS, 50 ng/ml, overnight) using mouse EBI3 antibody at 1.5 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-10J763-Flow-Cytometry-NBP2-03939-img0005.jpg)
![Western Blot: EBI3 Antibody (10J763) [NBP2-03939] - Western blot testing of mouse EBI3 monoclonal antibody at A) 0.1 ug/ml on recombinant protein and B) 3 ug/ml on recombinant mouse IL-35 protein Goat anti-rat Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/EBI3-Antibody-10J763-Western-Blot-NBP2-03939-img0001.jpg)
![Western Blot: TP63 Antibody (87C553) [NB100-56549] - analysis of p63 in mouse 1) placenta and 2) thymus using antibody at 3 ug/ml.](http://images.novusbio.com/fullsize/TP63-Antibody-87C553-Western-Blot-NB100-56549-img0003.jpg "Western Blot: TP63 Antibody (87C553) [NB100-56549] - analysis of p63 in mouse 1) placenta and 2) thymus using antibody at 3 ug/ml.")
![Western Blot: TP63 Antibody (87C553) [NB100-56549] - analysis of p63 in A549 lysate using p63 antibody at 3 ug/ml.](http://images.novusbio.com/fullsize/TP63-Antibody-87C553-Western-Blot-NB100-56549-img0002.jpg)
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Analysis using EBI3 antibody. Human EBI3 recombinant protein (A) and human IL-35 recombinant protein (B) probed with EBI3 antibody at 5 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-42N1G4-Western-Blot-NBP2-27356-img0004.jpg "Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Analysis using EBI3 antibody. Human EBI3 recombinant protein (A) and human IL-35 recombinant protein (B) probed with EBI3 antibody at 5 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Flow Cytometry: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Intracellular analysis of EBI3 in transfected cells using EBI3 antibody at 0.2 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-42N1G4-Flow-Cytometry-NBP2-27356-img0003.jpg)
![Western Blot: MKK3/MEK3 [p Ser189] Antibody [NB100-82048] - Analysis of extracts from 3T3 cells, treated with Anisomycin or calf intestinal phosphatase (CIP) NB100-82048](http://images.novusbio.com/fullsize/MKK3-MEK3-[p-Ser189]-Antibody-Western-Blot-NB100-82048-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: MKK3/MEK3 [p Ser189] Antibody [NB100-82048] - Analysis of extracts from 3T3 cells, treated with Anisomycin or calf intestinal phosphatase (CIP) NB100-82048")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: MKK3/MEK3 [p Ser189] Antibody [NB100-82048] - Staining of methanol-fixed Hela cells using NB100-82048](http://images.novusbio.com/fullsize/MKK3-MEK3-[p-Ser189]-Antibody-Immunocytochemistry-Immunofluorescence-NB100-82048-img0005.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: MKK3/MEK3 [p Ser189] Antibody [NB100-82048] - Analysis of extracts from Hela cells untreated or treated with PMA using MKK3(Phospho-Ser189) antibody](http://images.novusbio.com/fullsize/MKK3-MEK3-[p-Ser189]-Antibody-Western-Blot-NB100-82048-img0007.jpg)
![Immunohistochemistry-Paraffin: MKK3/MEK3 [p Ser189] Antibody [NB100-82048] - Immunohistochemical analysis of paraffin- embedded human breast carcinoma tissue, using NB100-82048(left) or the same antibody preincubated with blocking peptide (right).](http://images.novusbio.com/fullsize/nb100-82048_rabbit-polyclonal-mkk3-mek3-p-ser189-antibody-103202523464532.jpg)
![Western Blot: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Recombinant human endogenous soluble VEGFR-2/KDR (esKDR) was produced in insect cells. Western blot was performed using our monoclonal anti-VEGFR-2 recognizing the soluble as well as the transmembrane form of KDR (left panal) and our new poyclonal antibody directed against the unique C-terminal end of the endogenous sKDR (CGRETILDHSAEAVGMP) recognizing solely the endogenous form but not sKDR (D7) and sKDR (D7)-Fc consisting of the full extraplasmatic domain. The endogenous sKDR generated by alternative splicing consists of the first 6 Ig-like loops with a unique c-terminal end.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Western-Blot-NBP1-18646-img0006.jpg "Western Blot: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Recombinant human endogenous soluble VEGFR-2/KDR (esKDR) was produced in insect cells. Western blot was performed using our monoclonal anti-VEGFR-2 recognizing the soluble as well as the transmembrane form of KDR (left panal) and our new poyclonal antibody directed against the unique C-terminal end of the endogenous sKDR (CGRETILDHSAEAVGMP) recognizing solely the endogenous form but not sKDR (D7) and sKDR (D7)-Fc consisting of the full extraplasmatic domain. The endogenous sKDR generated by alternative splicing consists of the first 6 Ig-like loops with a unique c-terminal end.")
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - HMEC-1 CRL-3243 cells, stained with 1:50 VEGFR2/KDR/Flk-1 antibody (NBP1-18645AF488) (green) and DAPI (blue). Image from verified customer review.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP1-18646-img0016.jpg)
![Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Analysis with primary human dermal lymphatic endothelial cells(HDLEC).](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Flow-Cytometry-NBP1-18646-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (20I6) - Azide and BSA Free [NBP1-18646] - VEGFR2/KDR/Flk-1 Antibody (20I6) [NBP1-18646] - Staining (green) of VEGFR-2 (KDR) in primary human umbilical vein endothelial cells (HUVEC) with anti-human VEGFR-2 (Cl.4) (7,5ug/ml) and counter staining of nuclei with Dapi. As secondary antibody goat anti-mouse ALEXA Flour 488 (Dianova) was used 1:600.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-20I6-Immunocytochemistry-Immunofluorescence-NBP1-18646-img0015.jpg)
![Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (4H3) - Azide and BSA Free [NBP1-18644] - VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - IF double staining of human KDR in a co-culture of PAE-Flt-1, PAE-KDR and PAE-FLT-4 with (A) mouse anti-human KDR, (B) rabbit antihuman KDR (C) DAPI and (D) merged. Conjugated secondary antibody: goat anti-rabbit ALEXA Flour (1:600) and goat anti-mouse PE.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-4H3-Immunocytochemistry-Immunofluorescence-NBP1-18644-img0017.jpg "Immunocytochemistry/Immunofluorescence: VEGFR2/KDR/Flk-1 Antibody (4H3) - Azide and BSA Free [NBP1-18644] - VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - IF double staining of human KDR in a co-culture of PAE-Flt-1, PAE-KDR and PAE-FLT-4 with (A) mouse anti-human KDR, (B) rabbit antihuman KDR (C) DAPI and (D) merged. Conjugated secondary antibody: goat anti-rabbit ALEXA Flour (1:600) and goat anti-mouse PE.")
![Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - Analysis using the Biotin conjugate of NBP1-18644. Staining of VEGFR-2/KDR expression in HUVE cells.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-4H3-Flow-Cytometry-NBP1-18644-img0011.jpg)
![Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - Fig. 1: Flow analysis of VEGF R2/KDR/Flk-1 expression in primary human dermal mivrovascular endothelial cells (HDMVEC) and human umbilical vein endothelial cells (HUVEC).](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-4H3-Flow-Cytometry-NBP1-18644-img0008.jpg)
![ELISA: VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - 1 Sandwich-ELISA using soluble KDR (D7) as standard. Mouse anti-human VEGFR-2 was used as capture antibody, Biotinylated rabbit anti-human VEGFR-2 was used for detection.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-4H3-ELISA-NBP1-18644-img0006.jpg)
![ELISA: VEGFR2/KDR/Flk-1 Antibody (4H3) [NBP1-18644] - Total lysate from PAE/KDR cells was measured for expression of VEGFR- 1/KDR by a standard Sandwich ELISA using a mouse monoclonal anti-human VEGFR-1 antibody for capturing and a Biotin conjugated rabbit polyclonal anti-human VEGFR-1 antibody for detection. Total lysate from PAE/Flt-1 and PAE/FLT-4 was used as negative control. As positive control, total lysate from PAE/Flt-1 was spiked with recombinant human sKDR.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-4H3-ELISA-NBP1-18644-img0018.jpg)
![Western Blot: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Analysis of MAP2K3 expression in transfected 293T cell line by MAP2K3 monoclonal antibody (M02), clone 1D10.Lane 1: MAP2K3 transfected lysate (Predicted MW: 39.3 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/MKK3-MEK3-Antibody-1D10-Western-Blot-H00005606-M02-img0010.jpg "Western Blot: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Analysis of MAP2K3 expression in transfected 293T cell line by MAP2K3 monoclonal antibody (M02), clone 1D10.Lane 1: MAP2K3 transfected lysate (Predicted MW: 39.3 KDa).Lane 2: Non-transfected lysate.")
![Immunohistochemistry-Paraffin: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Analysis of monoclonal antibody to MAP2K3 on formalin-fixed paraffin-embedded human dysgerminoma. Antibody concentration 3 ug/ml.](http://images.novusbio.com/fullsize/MKK3-MEK3-Antibody-1D10-Immunohistochemistry-Paraffin-H00005606-M02-img0007.jpg)
![Western Blot: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Western Blot analysis of MAP2K3 expression in Hela NE ( Cat # L013V3 ).](http://images.novusbio.com/fullsize/MKK3-MEK3-Antibody-1D10-Western-Blot-H00005606-M02-img0001.jpg)
![Immunoprecipitation: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Analysis of MAP2K3 transfected lysate using anti-MAP2K3 monoclonal antibody and Protein A Magnetic Bead, and immunoblotted with MAP2K3 monoclonal antibody.](http://images.novusbio.com/fullsize/MKK3-MEK3-Antibody-1D10-Immunoprecipitation-H00005606-M02-img0008.jpg)
![Sandwich ELISA: MKK3/MEK3 Antibody (1D10) [H00005606-M02] - Detection limit for recombinant GST tagged MAP2K3 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/MKK3-MEK3-Antibody-1D10-Sandwich-ELISA-H00005606-M02-img0009.jpg)
![Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in MCF-7 (Cat # L046V1).](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Western-Blot-H00010000-M03-img0012.jpg "Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in MCF-7 (Cat # L046V1).")
![Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in HeLa (Cat # L013V1).](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Western-Blot-H00010000-M03-img0009.jpg)
![Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in PC-12 (Cat # L012V1).](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Western-Blot-H00010000-M03-img0010.jpg)
![Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in Raw 264.7 (Cat # L024V1).](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Western-Blot-H00010000-M03-img0011.jpg)
![Western Blot: Akt3 Antibody (3F3) [H00010000-M03] - Analysis of AKT3 expression in NIH/3T3 (Cat # L018V1).](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Western-Blot-H00010000-M03-img0013.jpg)
![ELISA: Akt3 Antibody (3F3) [H00010000-M03] - Detection limit for recombinant GST tagged AKT3 is approximately 0.3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-ELISA-H00010000-M03-img0006.jpg)
![Sandwich ELISA: Akt3 Antibody (3F3) [H00010000-M03] - Detection limit for recombinant GST tagged AKT3 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/Akt3-Antibody-3F3-Sandwich-ELISA-H00010000-M03-img0008.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0011.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining in human placenta and tonsil tissues. Corresponding FLT1 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Lane 1: Marker [kDa] Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Western-Blot-NBP2-30982-img0005.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0007.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human kidney shows strong cytoplasmic positivity in endothelial cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0008.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human small intestine shows moderate to strong cytoplasmic positivity in endothelial cells, as well as positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0009.jpg)
![Immunohistochemistry-Paraffin: VEGFR1/Flt-1 Antibody (CL0345) [NBP2-30982] - Staining of human tonsil shows no positivity in lymphoid cells as expected.](http://images.novusbio.com/fullsize/VEGFR1-Flt-1-Antibody-CL0345-Immunohistochemistry-Paraffin-NBP2-30982-img0010.jpg)
![Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human lymph node.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0007.jpg "Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human lymph node.")
![Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human colon shows low expression as expected.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0002.jpg)
![Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human pancreas shows high expression.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0003.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining in human pancreas and colon tissues using anti-PDIA2 antibody. Corresponding PDIA2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0004.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human kidney, liver, lymph node and pancreas using Anti-PDIA2 antibody NBP2-49015 (A) shows similar protein distribution across tissues to independent antibody NBP2-49086 (B).](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0005.jpg)
![Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human kidney.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0006.jpg)
![Immunohistochemistry-Paraffin: PDI Antibody [NBP2-49015] - Staining of human liver.](http://images.novusbio.com/fullsize/PDI-Antibody-Immunohistochemistry-Paraffin-NBP2-49015-img0008.jpg)
![Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Analysis in human heart muscle and endometrium tissues. Corresponding MYH6 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/MYH6-Antibody-Immunohistochemistry-Paraffin-NBP1-88120-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Analysis in human heart muscle and endometrium tissues. Corresponding MYH6 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Staining of human heart muscle shows moderate cytoplasmic positivity in cardiomyocytes.](http://images.novusbio.com/fullsize/MYH6-Antibody-Immunohistochemistry-Paraffin-NBP1-88120-img0008.jpg)
![Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Staining of human endometrium shows no positivity in glandular cells as expected.](http://images.novusbio.com/fullsize/MYH6-Antibody-Immunohistochemistry-Paraffin-NBP1-88120-img0007.jpg)
![Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Staining of human skeletal muscle shows moderate cytoplasmic positivity in a subset of myocytes.](http://images.novusbio.com/fullsize/MYH6-Antibody-Immunohistochemistry-Paraffin-NBP1-88120-img0010.jpg)
![Immunohistochemistry-Paraffin: MYH6 Antibody [NBP1-88120] - Staining of human prostate shows no positivity in smooth muscle cells as expected.](http://images.novusbio.com/fullsize/MYH6-Antibody-Immunohistochemistry-Paraffin-NBP1-88120-img0009.jpg)